β- Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension

C. Farsang, K. Varga, L. Vajda, J. Kapocsi, E Andrew Balas, G. Kunos

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Naloxone [0.4 mg iv.] increased blood pressure and heart rate of 13 clonidine-treated [0.3 mg per os for 3 days] patients with essential hypertension [reacting group] while it has no such effect in 11 clonidine-treated patients [non-reacting gr.] Clonidine increased plasma β-endorphin concentration of the reacting patients by 17.53 ± 1.68 pM/l and in the non-reacting ones by 5.91 ±0.88 pM/l. Significant linear correlation was found between the clonidine-induced increase in plasma β-endorphin level and the naloxone-induced change in mean blood pressure [r=0.9572,n:24, p<0.001]. In another group of 8 patients clonidine [0.15 mg iv.] decreased mean blood pressure but naloxone, 30 min after the clonidine injection, did not reverse the clonidine hypotension. We suggest that β-endorphin, released by chr.clonidine therapy, contributes to the antihypertensive effect only in the reacting group.

Original languageEnglish (US)
Pages (from-to)293-302
Number of pages10
JournalNeuropeptides
Volume4
Issue number4
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Endorphins
Clonidine
Antihypertensive Agents
Blood pressure
Naloxone
Blood Pressure
Plasmas
Essential Hypertension
Hypotension
Heart Rate
Injections

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Neuroscience(all)
  • Cellular and Molecular Neuroscience

Cite this

β- Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension. / Farsang, C.; Varga, K.; Vajda, L.; Kapocsi, J.; Balas, E Andrew; Kunos, G.

In: Neuropeptides, Vol. 4, No. 4, 01.01.1984, p. 293-302.

Research output: Contribution to journalArticle

Farsang, C. ; Varga, K. ; Vajda, L. ; Kapocsi, J. ; Balas, E Andrew ; Kunos, G. / β- Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension. In: Neuropeptides. 1984 ; Vol. 4, No. 4. pp. 293-302.
@article{5494c7974340491c993712debed98c09,
title = "β- Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension",
abstract = "Naloxone [0.4 mg iv.] increased blood pressure and heart rate of 13 clonidine-treated [0.3 mg per os for 3 days] patients with essential hypertension [reacting group] while it has no such effect in 11 clonidine-treated patients [non-reacting gr.] Clonidine increased plasma β-endorphin concentration of the reacting patients by 17.53 ± 1.68 pM/l and in the non-reacting ones by 5.91 ±0.88 pM/l. Significant linear correlation was found between the clonidine-induced increase in plasma β-endorphin level and the naloxone-induced change in mean blood pressure [r=0.9572,n:24, p<0.001]. In another group of 8 patients clonidine [0.15 mg iv.] decreased mean blood pressure but naloxone, 30 min after the clonidine injection, did not reverse the clonidine hypotension. We suggest that β-endorphin, released by chr.clonidine therapy, contributes to the antihypertensive effect only in the reacting group.",
author = "C. Farsang and K. Varga and L. Vajda and J. Kapocsi and Balas, {E Andrew} and G. Kunos",
year = "1984",
month = "1",
day = "1",
doi = "10.1016/0143-4179(84)90003-9",
language = "English (US)",
volume = "4",
pages = "293--302",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - β- Endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension

AU - Farsang, C.

AU - Varga, K.

AU - Vajda, L.

AU - Kapocsi, J.

AU - Balas, E Andrew

AU - Kunos, G.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Naloxone [0.4 mg iv.] increased blood pressure and heart rate of 13 clonidine-treated [0.3 mg per os for 3 days] patients with essential hypertension [reacting group] while it has no such effect in 11 clonidine-treated patients [non-reacting gr.] Clonidine increased plasma β-endorphin concentration of the reacting patients by 17.53 ± 1.68 pM/l and in the non-reacting ones by 5.91 ±0.88 pM/l. Significant linear correlation was found between the clonidine-induced increase in plasma β-endorphin level and the naloxone-induced change in mean blood pressure [r=0.9572,n:24, p<0.001]. In another group of 8 patients clonidine [0.15 mg iv.] decreased mean blood pressure but naloxone, 30 min after the clonidine injection, did not reverse the clonidine hypotension. We suggest that β-endorphin, released by chr.clonidine therapy, contributes to the antihypertensive effect only in the reacting group.

AB - Naloxone [0.4 mg iv.] increased blood pressure and heart rate of 13 clonidine-treated [0.3 mg per os for 3 days] patients with essential hypertension [reacting group] while it has no such effect in 11 clonidine-treated patients [non-reacting gr.] Clonidine increased plasma β-endorphin concentration of the reacting patients by 17.53 ± 1.68 pM/l and in the non-reacting ones by 5.91 ±0.88 pM/l. Significant linear correlation was found between the clonidine-induced increase in plasma β-endorphin level and the naloxone-induced change in mean blood pressure [r=0.9572,n:24, p<0.001]. In another group of 8 patients clonidine [0.15 mg iv.] decreased mean blood pressure but naloxone, 30 min after the clonidine injection, did not reverse the clonidine hypotension. We suggest that β-endorphin, released by chr.clonidine therapy, contributes to the antihypertensive effect only in the reacting group.

UR - http://www.scopus.com/inward/record.url?scp=0021615202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021615202&partnerID=8YFLogxK

U2 - 10.1016/0143-4179(84)90003-9

DO - 10.1016/0143-4179(84)90003-9

M3 - Article

VL - 4

SP - 293

EP - 302

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 4

ER -